Episode 23: Inish O'Doherty, PhD, Executive Director, Type 1 Diabetes (T1D) and Transplant Therapeutics (TTC) Consortium at C-Path

<p>In this episode, Inish O'Doherty joins Monica Westley to discuss his work which focuses on the collaborative selection and development of prognostic biomarkers that can be qualified as Drug Development Tools (DDT) and Novel Methodologies with the FDA and EMA, respectively. Dr. O'Doherty is the Executive Director of C-Path’s Type 1 Diabetes (T1D) and Transplant Therapeutic Consortium (TTC).</p> <p>To learn more about the ongoing research at C-Path, click on the link below</p> <p><a href='https://c-path.org/#5'>C-Path Website</a></p>